Contra-indicated in patients with, or at risk for, urinary retention, gastric retention or uncontrolled narrow-angle glaucoma.
- TRADE NAMES: Emselex (Novartis); Enablex (Novartis)
- INDICATIONS: Overactive bladder
- CLASS: Anticholinergic, Muscarinic antagonist
- HALF-LIFE: 13–19 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Anticholinergics, Antihistamines, Atazanavir, Clozapine, Cyclosporine, Digoxin, Disopyramide, Domperidone, Erythromycin, Flecainide, Fosamprenavir, Haloperidol, Imipramine, Indinavir, Itraconazole, Ketoconazole, Levodopa, Lopinavir, MAO inhibitors, Memantine, Metoclopramide, Nefopam, Nelfinavir, Nitrates (sublingual), Parasympathomimetics, Paroxetine Hydrochloride, Phenothiazines, Potent CYP3A4 inhibitors, Ritonavir, Saquinavir, Thioridazine, Tipranavir, Tricyclic antidepressants, Verapamil
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
